BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17116802)

  • 1. MKK4 status predicts survival after resection of gastric adenocarcinoma.
    Cunningham SC; Kamangar F; Kim MP; Hammoud S; Haque R; Iacobuzio-Donahue C; Ashfaq R; Kern SE; Maitra A; Heitmiller RE; Choti MA; Lillemoe KD; Cameron JL; Yeo CJ; Montgomery E; Schulick RD
    Arch Surg; 2006 Nov; 141(11):1095-9; discussion 1100. PubMed ID: 17116802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions.
    Cunningham SC; Kamangar F; Kim MP; Hammoud S; Haque R; Iacobuzio-Donahue CA; Maitra A; Ashfaq R; Hustinx S; Heitmiller RE; Choti MA; Lillemoe KD; Cameron JL; Yeo CJ; Schulick RD; Montgomery E
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):281-7. PubMed ID: 16492916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.
    Tascilar M; Skinner HG; Rosty C; Sohn T; Wilentz RE; Offerhaus GJ; Adsay V; Abrams RA; Cameron JL; Kern SE; Yeo CJ; Hruban RH; Goggins M
    Clin Cancer Res; 2001 Dec; 7(12):4115-21. PubMed ID: 11751510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
    Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA
    Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.
    Juuti A; Louhimo J; Nordling S; Ristimäki A; Haglund C
    J Clin Pathol; 2006 Apr; 59(4):382-6. PubMed ID: 16467169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric cancer: establishing predictors of biologic behavior with use of population-based data.
    Dicken BJ; Saunders LD; Jhangri GS; de Gara C; Cass C; Andrews S; Hamilton SM
    Ann Surg Oncol; 2004 Jun; 11(6):629-35. PubMed ID: 15150070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term survival of curatively operated gastric cancer: influence of the gender and splenectomy].
    Schafmayer C; Jürgens G; Jürgens I; Klomp HJ; Fändrich F; Kahlke V
    Zentralbl Chir; 2007 Dec; 132(6):515-22. PubMed ID: 18098079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma.
    Gold JS; Tang LH; Gönen M; Coit DG; Brennan MF; Allen PJ
    Ann Surg Oncol; 2007 Nov; 14(11):3159-67. PubMed ID: 17680313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAP2K4/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course.
    Xin W; Yun KJ; Ricci F; Zahurak M; Qiu W; Su GH; Yeo CJ; Hruban RH; Kern SE; Iacobuzio-Donahue CA
    Clin Cancer Res; 2004 Dec; 10(24):8516-20. PubMed ID: 15623633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma.
    Song KY; Jung CK; Park WS; Park CH
    Jpn J Clin Oncol; 2009 May; 39(5):290-6. PubMed ID: 19336448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.
    Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
    Ann Surg Oncol; 2007 Oct; 14(10):2721-9. PubMed ID: 17564748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
    Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
    Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
    Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
    J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.
    Marchet A; Mocellin S; Ambrosi A; de Manzoni G; Di Leo A; Marrelli D; Roviello F; Morgagni P; Saragoni L; Natalini G; De Santis F; Baiocchi L; Coniglio A; Nitti D;
    Eur J Surg Oncol; 2008 Feb; 34(2):159-65. PubMed ID: 17566691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival.
    Vagenas K; Spyropoulos C; Gavala V; Tsamandas AC
    J Surg Res; 2007 May; 139(2):182-8. PubMed ID: 17270215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome.
    Chatterjee D; Sabo E; Tavares R; Resnick MB
    Clin Cancer Res; 2008 May; 14(10):2994-3001. PubMed ID: 18483365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of transcription factor Sp1 in human gastric cancer tissue and its correlation with prognosis].
    Wang LW; Li Q; Hua ZL; Zhou F; Keping X; Daoyan W; Yao J; Ajani J
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):107-11. PubMed ID: 17645844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage-specific effect of adjuvant therapy following gastric cancer resection: a population-based analysis of 4,041 patients.
    Coburn NG; Govindarajan A; Law CH; Guller U; Kiss A; Ringash J; Swallow CJ; Baxter NN
    Ann Surg Oncol; 2008 Feb; 15(2):500-7. PubMed ID: 18026800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.